首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection
【24h】

Co-release of dicloxacillin and thioridazine from catheter material containing an interpenetrating polymer network for inhibiting device-associated Staphylococcus aureus infection

机译:从含有互穿聚合物网络的导管材料中共释放双氯西林和硫代哒嗪,以抑制与装置相关的金黄色葡萄球菌感染

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Approximately half of all nosocomial bloodstream infections are caused by bacterial colonization of vascular catheters. Attempts have been made to improve devices using anti-adhesive or antimicrobial coatings; however, it is often difficult to bind coatings stably to catheter materials, and the low amounts of drug in thin-film coatings limit effective long-term release. Interpenetrating polymer networks (IPNs) are polymer hybrid materials with unique drug release properties. While IPNs have been extensively investigated for use in tablet-or capsule-based drug delivery systems, the potential for use of IPNs in drug release medical devices remains largely unexplored. Here, we investigated the use of silicone-hydrogel IPNs as a catheter material to provide slow antibacterial drug-release functionality. IPN catheters were produced by the sequential method, using supercritical CO2 as a solvent to polymerize and crosslink poly(2-hydroxyethyl methacrylate) (PHEMA) in silicone elastomer. The design was tested against Staphylococcus aureus colonization after loading with dicloxacillin (DCX) alone or in combination with thioridazine (TDZ), the latter of which is known to synergistically potentiate the antibacterial effect of DCX against both methicillin-sensitive and methicillin-resistant S. aureus. The hydrophilic PHEMA component allowed for drug loading in the catheters by passive diffusion and provided controlled release properties. The drug-loaded IPN material inhibited bacterial growth on agar plates for up to two weeks and in blood cultures for up to five days, and it withstood 24 h of seeding with resilient biofilm aggregates. The combined loading of DCX + TDZ enhanced the antibacterial efficiency in static in vitro experiments, although release analyses revealed that this effect was due to an enhanced loading capacity of DCX when co-loaded with TDZ. Lastly, the IPN catheters were tested in a novel porcine model of central venous catheter-related infection, in which drug-loaded IPN catheters were found to significantly decrease the frequency of infection. (C) 2016 Elsevier B.V. All rights reserved.
机译:所有医院血流感染中约有一半是由血管导管细菌定植引起的。已经尝试改善使用抗粘或抗微生物涂层的装置;然而,本发明不限于此。然而,将涂层稳定地粘合到导管材料上通常很困难,并且薄膜涂层中的药物含量低限制了有效的长期释放。互穿聚合物网络(IPN)是具有独特药物释放特性的聚合物杂化材料。虽然已经广泛研究了IPN在基于片剂或胶囊的药物输送系统中的用途,但在药物释放医疗设备中使用IPN的潜力仍未得到充分探索。在这里,我们调查了有机硅-水凝胶IPNs作为导管材料的使用,以提供缓慢的抗菌药物释放功能。 IPN导管是通过顺序方法生产的,使用超临界CO2作为溶剂聚合和交联有机硅弹性体中的聚(甲基丙烯酸2-羟乙酯)(PHEMA)。在单独加载双氯西林(DCX)或与硫代哒嗪(TDZ)组合使用后,对该设计进行了抗金黄色葡萄球菌定植的测试,已知后者的协同作用可增强DCX对甲氧西林敏感和耐甲氧西林的S的抗菌作用。金黄色的。亲水性PHEMA成分允许药物通过被动扩散装载在导管中,并提供受控的释放特性。载有IPN的药物可在琼脂板上抑制细菌生长长达两周,而在血液培养中抑制细菌生长长达五天,并且可以抵御播种24 h的弹性生物膜聚集物。在静态体外实验中,DCX + TDZ的组合加载增强了抗菌效率,尽管释放分析表明,这种效果是由于与TDZ共同加载时DCX的加载能力增强所致。最后,在新型猪中央静脉导管相关感染的猪模型中测试了IPN导管,发现载有药物的IPN导管可显着降低感染频率。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号